Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Nov 16, 2015 · 10-Q · 47 days after period end · 0001144204-15-065865
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Net Income | -$838.89K | -$783.30K | -$571.51K | -$492.68K |
| EPS Diluted | $0.00 | -$0.01 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 16, 2015 · 47 d after period end
